Trials / Active Not Recruiting
Active Not RecruitingNCT05074160
OCS Liver Perfusion (OLP) Post-Approval Registry
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 166 (actual)
- Sponsor
- TransMedics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.
Detailed description
OLP Registry is a multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OCS Liver | Multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below. |
Timeline
- Start date
- 2021-10-14
- Primary completion
- 2024-03-22
- Completion
- 2026-06-01
- First posted
- 2021-10-12
- Last updated
- 2025-04-10
Locations
9 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05074160. Inclusion in this directory is not an endorsement.